These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8319613

  • 1. Platinum drug-DNA interactions in human tissues measured by cisplatin-DNA enzyme-linked immunosorbent assay and atomic absorbance spectroscopy.
    Poirier MC, Reed E, Shamkhani H, Tarone RE, Gupta-Burt S.
    Environ Health Perspect; 1993 Mar; 99():149-54. PubMed ID: 8319613
    [Abstract] [Full Text] [Related]

  • 2. Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients.
    Poirier MC, Reed E, Litterst CL, Katz D, Gupta-Burt S.
    Cancer Res; 1992 Jan 01; 52(1):149-53. PubMed ID: 1727376
    [Abstract] [Full Text] [Related]

  • 3. Platinum-DNA adducts assayed in leukocytes of patients with germ cell tumors measured by atomic absorbance spectrometry and enzyme-linked immunosorbent assay.
    Motzer RJ, Reed E, Perera F, Tang D, Shamkhani H, Poirier MC, Tsai WY, Parker RJ, Bosl GJ.
    Cancer; 1994 Jun 01; 73(11):2843-52. PubMed ID: 7514956
    [Abstract] [Full Text] [Related]

  • 4. Characterization of the DNA damage recognized by an antiserum elicited against cis-diamminedichloroplatinum (II)-modified DNA.
    Reed E, Gupta-Burt S, Litterst CL, Poirier MC.
    Carcinogenesis; 1990 Dec 01; 11(12):2117-21. PubMed ID: 1979937
    [Abstract] [Full Text] [Related]

  • 5. Relationship between patient response in ovarian and breast cancer and platinum drug-DNA adduct formation.
    Gupta-Burt S, Shamkhani H, Reed E, Tarone RE, Allegra CJ, Pai LH, Poirier MC.
    Cancer Epidemiol Biomarkers Prev; 1993 Dec 01; 2(3):229-34. PubMed ID: 8318875
    [Abstract] [Full Text] [Related]

  • 6. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A, Apostoli P, Zaninelli M, Pavanel F, Colombatti M, Cetto GL, Franceschi T, Sperotto L, Leone R.
    Clin Cancer Res; 1996 Nov 01; 2(11):1829-35. PubMed ID: 9816137
    [Abstract] [Full Text] [Related]

  • 7. Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry.
    Parker RJ, Gill I, Tarone R, Vionnet JA, Grunberg S, Muggia FM, Reed E.
    Carcinogenesis; 1991 Jul 01; 12(7):1253-8. PubMed ID: 2070490
    [Abstract] [Full Text] [Related]

  • 8. DNA adducts of cisplatin and carboplatin in tissues of cancer patients.
    Poirier MC, Egorin MJ, Fichtinger-Schepman AM, Yuspa SH, Reed E.
    IARC Sci Publ; 1988 Jul 01; (89):313-20. PubMed ID: 3058599
    [Abstract] [Full Text] [Related]

  • 9. DNA adducts in human and patas monkey maternal and fetal tissues induced by platinum drug chemotherapy.
    Shamkhani H, Anderson LM, Henderson CE, Moskal TJ, Runowicz CD, Dove LF, Jones AB, Chaney SG, Rice JM, Poirier MC.
    Reprod Toxicol; 1994 Jul 01; 8(3):207-16. PubMed ID: 8075509
    [Abstract] [Full Text] [Related]

  • 10. Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation.
    Fichtinger-Schepman AM, van der Velde-Visser SD, van Dijk-Knijnenburg HC, van Oosterom AT, Baan RA, Berends F.
    Cancer Res; 1990 Dec 15; 50(24):7887-94. PubMed ID: 2253228
    [Abstract] [Full Text] [Related]

  • 11. Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy.
    Peng B, Tilby MJ, English MW, Price L, Pearson AD, Boddy AV, Newell DR.
    Br J Cancer; 1997 Dec 15; 76(11):1466-73. PubMed ID: 9400943
    [Abstract] [Full Text] [Related]

  • 12. Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma.
    Fichtinger-Schepman AM, Vendrik CP, van Dijk-Knijnenburg WC, de Jong WH, van der Minnen AC, Claessen AM, van der Velde-Visser SD, de Groot G, Wubs KL, Steerenberg PA.
    Cancer Res; 1989 Jun 01; 49(11):2862-7. PubMed ID: 2720647
    [Abstract] [Full Text] [Related]

  • 13. Relationship between platinum-DNA adducts in leukocytes of patients with advanced germ cell cancer and survival.
    Fisch MJ, Howard KL, Einhorn LH, Sledge GW.
    Clin Cancer Res; 1996 Jun 01; 2(6):1063-6. PubMed ID: 9816268
    [Abstract] [Full Text] [Related]

  • 14. Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitro.
    Dabholkar M, Bradshaw L, Parker RJ, Gill I, Bostick-Bruton F, Muggia FM, Reed E.
    Environ Health Perspect; 1992 Nov 01; 98():53-9. PubMed ID: 1486863
    [Abstract] [Full Text] [Related]

  • 15. Improved 32P-postlabelling assay for the quantification of the major platinum-DNA adducts.
    Welters MJ, Maliepaard M, Jacobs-Bergmans AJ, Baan RA, Schellens JH, Ma J, van der Vijgh WJ, Braakhuis BJ, Fichtinger-Schepman AM.
    Carcinogenesis; 1997 Sep 01; 18(9):1767-74. PubMed ID: 9328174
    [Abstract] [Full Text] [Related]

  • 16. Influence of the degree of DNA modification on the immunochemical determination of cisplatin-DNA adduct levels.
    Fichtinger-Schepman AM, Baan RA, Berends F.
    Carcinogenesis; 1989 Dec 01; 10(12):2367-9. PubMed ID: 2591026
    [Abstract] [Full Text] [Related]

  • 17. Cisplatin- and carboplatin-DNA adducts: is PT-AG the cytotoxic lesion?
    Fichtinger-Schepman AM, van Dijk-Knijnenburg HC, van der Velde-Visser SD, Berends F, Baan RA.
    Carcinogenesis; 1995 Oct 01; 16(10):2447-53. PubMed ID: 7586150
    [Abstract] [Full Text] [Related]

  • 18. Formation of DNA adducts by the anticancer drug carboplatin: different nucleotide sequence preferences in vitro and in cells.
    Blommaert FA, van Dijk-Knijnenburg HC, Dijt FJ, den Engelse L, Baan RA, Berends F, Fichtinger-Schepman AM.
    Biochemistry; 1995 Jul 04; 34(26):8474-80. PubMed ID: 7599137
    [Abstract] [Full Text] [Related]

  • 19. Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy.
    Veal GJ, Dias C, Price L, Parry A, Errington J, Hale J, Pearson AD, Boddy AV, Newell DR, Tilby MJ.
    Clin Cancer Res; 2001 Aug 04; 7(8):2205-12. PubMed ID: 11489793
    [Abstract] [Full Text] [Related]

  • 20. Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy.
    Reed E, Ozols RF, Tarone R, Yuspa SH, Poirier MC.
    Proc Natl Acad Sci U S A; 1987 Jul 04; 84(14):5024-8. PubMed ID: 3110781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.